HERBAL MEDICINAL PRODUCTS IN A TREATMENT OF MASTALGIA IN GYNECOLOGIC PATIENTS
https://doi.org/10.17650/1994-4098-2017-13-4-63-70
Abstract
Implementation of breast cancer screening using digital mammography improved the diagnosis of primary proliferative regressive structural changes in the breast, manifested as diffuse or diffusely-nodal deformations of tissues. Currently, women are significantly more likely to seek medical consultation for damages of the breast that could not be evaluated earlier. This requires the development of special tactics for their treatment and follow-up. Nowadays, searching for prognostic markers and choosing adequate therapy for nodular and diffuse mastopathy are among the most discussed issues in mammology, because up to 25 % of all breast cancer cases are diagnosed during the in situ phase. In this article we try to reassess the problem of dyshormonal changes in the breast and develop an optimal approach to their treatment.
About the Authors
A. G. Kedrova
Federal Research and Clinical Center for Specialized Medical Cares and Medical Technologies, Federal Medical and Biological Agency of Russia
Russian Federation
28 Orekhovyy Boulevard, Moscow 115682
Russian Federation
28 Orekhovyy Boulevard, Moscow 115682
S. A. Levakov
Institute for Advanced Training, Federal Medical and Biological Agency of Russia
Russian Federation
Russian Federation
91 Volokolamskoe Shosse, Moscow 125371
References
1. Seidlova-Wuttke D., Wuttke W. The premenstrual syndrome, premenstrual mastodynia, fibrocystic mastopathy and infertility have often common roots: effects of extracts of chasteberry (Vitex agnus-castus) as a solution. Clinical Phytoscience 2017;3:6. DOI: 10.1186/s40816-016-0038-z.
2. Halbreich U., Ben-David M., Assael M., Bornstein R. Serum-prolatic in women with premenstrual syndrome. Lancet 1976;2(7987):654–6. PMID: 60517.
3. Gumenyuk E.G. Some problems of premenstrual syndrome and alternative therapy. Journal of obstetrics and gynecological diseases 2010;2:38–45.
4. Зилбернагль С., Ланг Ф. Клиническая патофизиология. Атлас. М.: Практическая медицина, 2016. C. 282–284. [Silbernagl S., Lang F. Clinical pathophysiology. Atlas. Moscow: Prakticheskaya meditsina, 2016. Pp. 282–284. (In Russ.)].
5. Кулагина Н.В. Лечение диффузной дисгормональной дисплазии молочных желез у пациенток в периоде менопаузального перехода. Акушерство и гинекология 2016;11:136–42. [Kulagina N.V. Treatment of diffuse dyshormonal breast dysplasia in women at menopausal transition. Akusherstvo i ginekologiya = Obstetrics and Gynecology 2016;11:136–42. (In Russ.)].
6. Высоцкая И.В., Летягин В.П., Фармакологические эффекты и молекулярные механизмы действия лечебного фитопрепарата на основе Vitex agnus-castus. Опухоли женской репродуктивной системы 2017;1:14–9. [Vysotskaya I.V., Letyagin V.P., Pharmacological effects and molecular mechanisms of action of a herbal medicine containing Vitex agnus-castus. Opukholi zhenskoy reproduktivnoy sistemy = Tumors of Female Reproductive System 2017;1:14–9. (In Russ.)].
7. Williams A.C. Measures of function and psychology. In: Textbook of Pain. Eds.: P.D. Wall, R. Melzack. New York: Churchill Livingstone, 1999. Pp. 427–446.
8. Del Pozo E., Wyss H., Tollis G. et al. Prolactin and deficient luteal function. Obstet Gynecol 1979;53(3):282–6. PMID: 424097.
9. Damiano J.S., Wasserman E. Molecular pathways: blockade of the PRLR signaling pathway as a novel antihormonal approach for the treatment of breast and prostate cancer. Clin Cancer Res 2013;19(7):1644–50. DOI: 10.1158/1078-0432.CCR12-0138.
10. Schulz K.D., Del Pozo E., Lose K.H. et al. Successful treatment of mastodynia with the prolactin inhibitor bromocryptine (CB 154). Arch Gynakol 1975;220(1):83–7. PMID: 1243527.
11. Burton A., Maskarinec G., Perez-Gomez B. et al. Mammographic density and ageing: а collaborative pooled analysis of crosssectional data from 22 countries worldwide. PLoS Med 2017;14(6):e1002335. DOI: 10.1371/journal.pmed.1002335.
12. Murta E.F., de Freitas M.M., Velludo M.A. Histologic changes in fibrocystic breast disease before and after treatment with bromocriptine. Rev Paul Med 1992;110(6):251–6. PMID: 1341021.
13. Milewicz A., Gejdel E., Sworen H. et al. Vitex agnus-castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study. Arzneimittelforschung 1993;43(7):752–6. PMID: 8369008.
14. Turner S., Mills S. A double-blind clinical trial on a herbal remedy for premenstrual syndrome; a case study. Сomplementary therapies in medicine 1993;1(2):73–7. DOI: 10.1016/0965-2299(93)90096-V.
15. Lauritzen C.H., Reuter H.D., Repges R. et al. Treatment of premenstrual tension syndrome with Vitex agnus-castus: controlled, double-blind study versus pyridoxine. Phytomedicine 1997;4(3):183–9. DOI: 10.1016/S0944-7113(97)80066-9.
16. Wuttke W., Splitt G., Gorkow C., Sieder C. Treatment of cyclical mastalgia: Results of a randomized, placebo-controlled, double-blind study. Geburtshilfe Frauenheilkd 1997;57:569–74.
17. Halaška M., Rauš К., Bĕles P. et al. Treatment of cyclical mastodynia using an extract of Vitex agnus-castus: results of a double-blind comparison with a placebo. Ceška Gynekol 1998;63(5):388–92. PMID: 9818496.
18. Ma L., Lin S., Chen R., Wang X. Treatment of moderate to severe premenstrual syndrome with Vitex agnus-castus (BNO 1095) in Chinese women. Gynec Endocrinol 2010;26(8):612–6. DOI: 10.3109/09513591003632126.
19. Kilicdag E.B., Tarim E., Bagis T. et al. Fructus Vitex agnus-castus and bromocriptine for treatment of hyperprolactinemia and mastalgia. Int J Gyn Obs 2004;85(3):292–3.
20. Pakgohar M., Moradi M., Jamshidi A.H., Mehran A. Assessment of Vitex agnus-castus L. extract effect on treatment of premenstrual syndrome. J Med Plants 2009;8(32):98–107, 185.
21. Ciotta L., Pagano I., Stracquadanio M. et al. Psychic aspects of the premenstrual dysphoric disorders. New therapeutic strategies: our experience with Vitex agnus-castus. Minerva Ginecol 2011;63(3):237–45. PMID: 21654609.
22. Zamani M., Neghab N., Torabian S. Therapeutic effect of Vitex agnus-castus in patients with premenstrual syndrome. Acta Med Iran 2012;50(2):101–6. PMID: 22359078.
23. Burton A., Maskarinec G., Perez-Gomez B. et al. Mammographic density and ageing: а collaborative pooled analysis of crosssectional data from 22 countries worldwide. PLoS Med 2017;14(6): e1002335. DOI: 10.1371/journal.pmed.1002335.
Review
For citations:
Kedrova A.G., Levakov S.A. HERBAL MEDICINAL PRODUCTS IN A TREATMENT OF MASTALGIA IN GYNECOLOGIC PATIENTS. Tumors of female reproductive system. 2017;13(4):63-70. (In Russ.) https://doi.org/10.17650/1994-4098-2017-13-4-63-70
Views:
7826
Email this article 